HYPOPARATHYROIDISM
Clinical trials for HYPOPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new HYPOPARATHYROIDISM trials appear
Sign up with your email to follow new studies for HYPOPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New calcium pill could ease burden for hypoparathyroidism patients
Disease control OngoingThis study tests a new form of calcium called AMOR-1 in 81 adults with hypoparathyroidism, a condition where the body can't control calcium levels. Participants will take either AMOR-1 or standard calcium pills to see if AMOR-1 can better maintain normal calcium levels while allo…
Matched conditions: HYPOPARATHYROIDISM
Phase: PHASE2 • Sponsor: Amorphical Ltd. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New Once-Weekly shot shows promise for Long-Term hypoparathyroidism control
Disease control OngoingThis study looks at the long-term safety of an experimental drug called MBX 2109 for people with hypoparathyroidism, a condition where the body doesn't produce enough parathyroid hormone. About 60 adults who finished a 12-week phase 2 study will receive weekly injections of MBX 2…
Matched conditions: HYPOPARATHYROIDISM
Phase: PHASE2 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC